Status:
NOT_YET_RECRUITING
Accuracy of CBC Derived Markers Against CRP and ESR in Detecting Active Rheumatoid Arthritis in Upper Egypt
Lead Sponsor:
Assiut University
Conditions:
Rheumatic Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Rheumatoid arthritis (RA) is a chronic autoimmune disease that leads to persistent synovial inflammation, joint destruction, and disability, often with extra-articular manifestations like interstitial...
Eligibility Criteria
Inclusion
- 1-Adults aged ≥18 years. 2-Established RA diagnosis according to ACR/EULAR criteria {ACR: American College of Rheumatology, a professional organization of rheumatologists.
- EULAR: European League Against Rheumatism, a European organization for rheumatology.
- 3-Willing to provide informed consent
Exclusion
- 1-Presence of infection, malignancy, or other autoimmune diseases. 2-Recent use (within 4 weeks) of corticosteroids or immunosuppressive therapy. 3-Pregnant or lactating women.
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT07149194
Start Date
September 1 2025
End Date
October 1 2027
Last Update
August 29 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.